
Cardiologist

No OPD information available
Aortic Regurgitation
Angioplasty
Aortic Valve Stenosis
Coronary Heart Disease
Hypertension
Percutaneous Coronary Intervention (PCI)
Spontaneous Coronary Artery Dissection (SCAD)
Acute Coronary Syndrome
Angina
Aortic Valve Replacement
Calcinosis
Cardiac Ablation
Heart Attack
Robert J. Whitbourn is a male healthcare provider who helps patients with heart problems. He is skilled in treating conditions like Aortic Regurgitation, Angioplasty, Aortic Valve Stenosis, Coronary Heart Disease, Hypertension, and more. One important thing he does is called Percutaneous Coronary Intervention (PCI), which is a special way to fix heart blockages without surgery.
Robert J. Whitbourn is good at talking to patients and making them feel comfortable. Patients trust him because he listens carefully and explains things in a simple way. He also stays updated on the latest medical knowledge and research to provide the best care possible.
When working with other medical professionals, Robert J. Whitbourn is known for being a good team player. He shares information and ideas with colleagues to make sure patients get the best treatment. His work has had a positive impact on many patients' lives by helping them recover from heart problems and live healthier lives.
One of Robert J. Whitbourn's notable publications is about a treatment called Radiofrequency Renal Denervation. He also conducted a clinical trial on a special device called Absorb™ BVS for treating coronary artery lesions. These studies help improve treatments for heart conditions and show his dedication to advancing medical knowledge.
In summary, Robert J. Whitbourn is a caring and skilled healthcare provider who uses the latest treatments to help patients with heart problems. He communicates well with patients, stays updated on medical research, and works collaboratively with other medical professionals to provide the best care possible. His work has made a positive impact on many patients' lives, and his research contributions help advance heart treatments for the future.
Enrollment Status: Completed
Published: October 30, 2023
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
